LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease)
LeonaBio, Inc. (LONA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) of 1.91 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Notes
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease · last filed 2024-05-15
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for the quarter ending 2024-03-31 was 1.91M shares, a 0.78% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for the quarter ending 2023-12-31 was 0.00 shares.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for the quarter ending 2023-09-30 was 0.00 shares.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for the quarter ending 2023-06-30 was 0.00 shares.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for fiscal 2023 was 1.89M shares, a 1.33% increase from fiscal 2022.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for fiscal 2022 was 1.87M shares, a 15.06% increase from fiscal 2021.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease) for fiscal 2021 was 1.62M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2024-03-31 | 1.91M shares 10-Q · filed 2024-05-15 | 1.91M shares derived: sum of 2 quarters · filed 2024-05-15 | 1.91M shares derived: sum of 3 quarters · filed 2024-05-15 | 1.91M shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-22 | 0.00 shares derived: sum of 3 quarters · filed 2024-02-22 | 1.89M shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 1.89M shares 10-Q · filed 2023-11-09 | 1.89M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 1.89M shares 10-Q · filed 2023-08-10 | 1.89M shares derived: sum of 3 quarters · filed 2023-08-10 | 1.89M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 1.89M shares 10-Q · filed 2023-05-11 | 1.89M shares derived: sum of 2 quarters · filed 2023-05-11 | 1.89M shares derived: sum of 3 quarters · filed 2023-05-11 | 1.89M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-23 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-23 | 1.87M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-10 | 1.87M shares 10-Q · filed 2022-11-10 | 1.87M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.87M shares 10-Q · filed 2022-08-15 | 1.87M shares derived: sum of 3 quarters · filed 2022-08-15 | 1.87M shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 1.87M shares 10-Q · filed 2022-05-12 | 1.87M shares derived: sum of 2 quarters · filed 2022-05-12 | 1.87M shares derived: sum of 3 quarters · filed 2022-05-12 | 1.87M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-28 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-28 | 1.62M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-10 | 1.62M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 1.62M shares 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | 1.62M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |